Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721926 · ClinicalTrials.gov registry record · NA
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
A NA study of Other Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT03721926: Completed NA study of Other Cancer, sponsored by Massachusetts General Hospital.
NCT03721926 is a NA study of Other Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 91 participants, below the 3,249-participant average among 5 other Other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721926, a NA study of Other Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to develop a geriatric oncology collaborative care intervention to enhance the quality of life, symptom burden, and functional outcomes of older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancers.
Primary Outcome
To demonstrate feasibility, investigators will calculate rates of study enrollment (proportion of eligible patients who enroll in the study).
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Geriatric Oncology Collaborative Care
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT03721926 record still lists
NCT03721926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 3,249-participant average among 5 other Other Cancer trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Other Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03721926 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03721926 about?
NCT03721926 is a clinical study titled "A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer". The purpose of this research study is to develop a geriatric oncology collaborative care intervention to enhance the quality of life, symptom burden, and functional outcomes of older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancers.
What is the current status of trial NCT03721926?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2019-02-14. Estimated completion is 2022-03-31.
What conditions does trial NCT03721926 study?
This clinical trial studies the following conditions: Other Cancer.
What interventions are being tested in trial NCT03721926?
The interventions under investigation include: Usual Care (OTHER), Geriatric Oncology Collaborative Care (OTHER).
Who is sponsoring clinical trial NCT03721926?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03721926 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Other Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
RECRUITING · NA
-
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
ACTIVE NOT RECRUITING · NA
-
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
COMPLETED · NA
-
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
RECRUITING
-
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI